Building cross-border collaborations to increase diversity and accelerate rare disease drug development - meeting report from the inaugural IndoUSrare Annual Conference 2021.

Khera, Harvinder Kour; Venugopal, Nisha; Karur, Ramya T; Mishra, Rakesh; Kartha, Reena V; Rajasimha, Harsha K

Khera, Harvinder Kour; Venugopal, Nisha; Karur, Ramya T; Mishra, Rakesh; Kartha, Reena V; Rajasimha, Harsha K.

Afiliación

Khera HK; Tata Institute for Genetics and Society, Bengaluru, India.
Venugopal N; Indo US Organization for Rare Diseases, Herndon, VA, USA.
Karur RT; Indo US Organization for Rare Diseases, Herndon, VA, USA.
Mishra R; Tata Institute for Genetics and Society, Bengaluru, India.
Kartha RV; University of Minnesota Twin Cities, Minneapolis, MN, USA; Indo US Organization for Rare Diseases, Herndon, VA, USA.
Rajasimha HK; Indo US Organization for Rare Diseases, Herndon, VA 20171, USA.

Ther Adv Rare Dis ; 3: 26330040221133124, 2022.

Article en En | MEDLINE | ID: mdl-37180411